Form 8-K - Current report:
SEC Accession No. 0001213900-25-019479
Filing Date
2025-03-03
Accepted
2025-03-03 17:08:25
Documents
14
Period of Report
2025-02-27
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0232854-8k_pmgchold.htm   iXBRL 8-K 36496
2 MUTUAL TERMINATION OF LICENSE AGREEMENT DATED AS OF FEBRUARY 27, 2025, BY AND BE ea023285401ex10-1_pmgchold.htm EX-10.1 5296
  Complete submission text file 0001213900-25-019479.txt   223868

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE elab-20250227.xsd EX-101.SCH 3027
4 XBRL LABEL FILE elab-20250227_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE elab-20250227_pre.xml EX-101.PRE 22797
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0232854-8k_pmgchold_htm.xml XML 3963
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25699408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)